title: Glucagon-like peptide 1-based drugs and pancreatic safety.
authors.affiliation: Merck Sharp & Dohme Corporation, Whitehouse Station, New Jersey.
authors.forename: Kimberly G
authors.initials: KG
authors.lastname: Brodovicz
authors.forename: Samuel S
authors.initials: SS
authors.lastname: Engel
authors.forename: Nancy A
authors.initials: NA
authors.lastname: Thornberry
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D005260:Female; D052216:Glucagon-Like Peptide 1 / Q000009:adverse effects*; D006760:Hospitalization; D006801:Humans; D008297:Male; D010195:Pancreatitis / Q000139:chemically induced*
chemical_list: D052216:Glucagon-Like Peptide 1